Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
SHM joined dozens of other medical societies urging Congress to take immediate action to stop the impending 3.7 percent payment reduction, slated to go into effect January 1, 2024.
On January 12, 2023, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the immediate elimination of the X-Waiver for
SHM offered comments on the proposed Contract Year 2026 Medicare Advantage proposed rule strengthening rules around MA plan coverage criteria and prior authorizations.
SHM, joined by IDSA, ACEP, EDPMA, and ASA, sends letter to CMS on issues with the hospital-based exemption from the Promoting Interoperability category of the MIPS.
SHM submitted comments on the FY2020 Hospital Prospective Payment System proposed rule. Our comments address Inpatient Quality Reporting (IQR) measures related to hospital harms, opioid safety,
SHM has submitted comments on the COVID–19 Public Health Emergency interim final rule to CMS. SHM has voiced our support for many of the waivers and flexibilities issued for the duration of the
SHM, joined by other medical societies, signed a letter to CMS about the automation of the prior authorization process. We are concerned automating prior authorization, without focusing on other
SHM joined a multi-stakeholder letter urging the extension of telehealth flexibilities beyond the expiration of the PHE.
SHM has joined a multi-stakeholder letter to CMS, urging the agency to halt the implementation of their new split/shared billing policy,
SHM joined the AMA and other medical specialty societies, urging CMS to rescind the new policy on split (or shared) billing.